Bugspytkirtelkræft (Danish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bugspytkirtelkræft" in Danish language version.

refsWebsite

Global rank Danish rank

106nih.gov

4^th place

24^th place

76doi.org

2^nd place

13^th place

21web.archive.org

1^st place

8cancer.org

3,680^th place

low place

6cancer.gov

1,684^th place

4,834^th place

5oxfordjournals.org

1,389^th place

892^nd place

3archive.org

6^th place

12^th place

2jhu.edu

699^th place

1,992^nd place

2nccn.org

low place

2cancer.dk

low place

501^st place

1sundhed.dk

low place

166^th place

1enotes.us

low place

1wessexcolorectalclinic.com

low place

1zju.edu.cn

low place

1joplink.net

low place

1iarc.fr

4,025^th place

4,074^th place

1books.google.com

3^rd place

25^th place

1google.ca

838^th place

718^th place

1seen.es

low place

1cancerstaging.org

low place

1nhs.uk

1,989^th place

1,546^th place

1karger.com

4,489^th place

low place

1nature.com

234^th place

176^th place

1alabmed.com

low place

1onkologisktidsskrift.dk

low place

1medscape.com

719^th place

1,830^th place

1cancernetwork.com

low place

1medicin.dk

low place

242^nd place

1sciencedirect.com

149^th place

254^th place

1cancerresearchuk.org

8,489^th place

low place

1pancreaticcancer.net.au

low place

1harvard.edu

18^th place

119^th place

1europac-org.eu

low place

1worldcat.org

5^th place

36^th place

1wjgnet.com

low place

alabmed.com

Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (september 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)" (PDF). The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990-3011. doi:10.1210/jc.2012-1230. PMID 22723327. Arkiveret fra originalen (PDF) 17. februar 2015. Hentet 6. januar 2017.

archive.org

World Cancer Report 2014. World Health Organization. 2014. Chapter 5.7. ISBN 92-832-0429-8.
Alberts, SR; Goldberg, RM (2009). "Chapter 9: Gastrointestinal tract cancers". I Casciato, DA; Territo, MC (red.). Manual of clinical oncology. Lippincott Williams & Wilkins. s. 188–236. ISBN 978-0-7817-6884-9.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (2011). "Arterial resection during pancreatectomy for pancreatic cancer: A systematic review and meta-analysis". Annals of Surgery. 254 (6): 882-93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622.

books.google.com

Harris, RE (2013). "Epidemiology of pancreatic cancer". Epidemiology of Chronic Disease. Jones & Bartlett. s. 181-190. ISBN 978-0-7637-8047-0.

cancer.dk

cancer.gov

"What is Cancer? Defining Cancer". National Cancer Institute, National Institutes of Health. 7. marts 2014. Hentet 5. december 2014.
"Pancreatic Cancer Treatment (PDQ®) Patient Version". National Cancer Institute. National Institutes of Health. 17. april 2014. Hentet 8. juni 2014.
"Pancreatic Cancer Treatment (PDQ®) Health Professional Version". National Cancer Institute. National Institutes of Health. 21. februar 2014. Hentet 24. november 2014. "The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20% of cases. In cases with localized disease and small cancers (<2 cm) with no lymph node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is associated with an actuarial five-year survival rate of 18% to 24%."
National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality [4]
Everolimus Approved for Pancreatic Neuroendocrine Tumors Arkiveret 16. juli 2016 hos Wayback Machine The ASCO Post. May 15, 2011, Volume 2, Issue 8
National Cancer Institute. Cancer Drug Information. FDA Approval for Sunitinib Malate Arkiveret 5. januar 2015 hos Wayback Machine. Pancreatic Neuroendocrine Tumors

cancer.org

"Can pancreatic cancer be prevented?". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 13. november 2014. Hentet 13. november 2014.
"Cancer Facts & Figures 2010" (PDF). American Cancer Society. 2010. Arkiveret fra originalen (PDF) 14. januar 2015. Hentet 5. december 2014. See p. 4 for incidence estimates, and p. 19 for survival percentages.
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Arkiveret fra originalen (PDF) 18. december 2014. Hentet 5. januar 2015., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
"Staging of pancreatic cancer". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 10. august 2020. Hentet 29. september 2014.
"Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section". American Cancer Society. 20. august 2012. Arkiveret fra originalen 4. november 2014. Hentet 4. november 2014.
"Palliative or Supportive Care". American Cancer Society. 2014. Arkiveret fra originalen 21. august 2014. Hentet 20. august 2014.
"If treatment for pancreatic cancer stops working". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 2014-10-22. Hentet 20. august 2014.
"What's new in pancreatic cancer research and treatment?". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 29. november 2016. Hentet 17. juli 2014.

cancernetwork.com

Text is available electronically (but may require free registration) See: Benson AB, Myerson RJ, Sasson AR. Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach 13th edition 2010. ISBN 978-0-615-41824-7. Arkiveret fra originalen 15. maj 2011. Hentet 7. januar 2017.

cancerresearchuk.org

"Pancreatic cancer research". Cancer Research UK. Arkiveret fra originalen 18. februar 2014. Hentet 17. juli 2014.

cancerstaging.org

"Chapter 15; Pancreas". Manual for Staging of Cancer (PDF) (2nd udgave). American Joint Committee on Cancer. s. 95-8. See page 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."

doi.org

Ryan DP, Hong TS, Bardeesy N (september 2014). "Pancreatic adenocarcinoma" (PDF). N. Engl. J. Med. 371 (11): 1039-49. doi:10.1056/NEJMra1404198. PMID 25207767. Arkiveret fra originalen (PDF) 26. december 2014. Hentet 5. januar 2017.
Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma" (PDF). BMJ (Clinical research ed.). 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847. Arkiveret fra originalen (PDF) 9. januar 2015. Hentet 5. januar 2017.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (september 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318-48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (august 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607-20. doi:10.1016/S0140-6736(10)62307-0. PMID 21620466. Arkiveret fra originalen (PDF) 12. januar 2015. Hentet 5. januar 2017.
Shahrokni A, Saif MW (10. juli 2013). "Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life". JOP : Journal of the pancreas. 14 (4): 391-4. doi:10.6092/1590-8577/1663. PMID 23846935.
Bardou M, Le Ray I (december 2013). "Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies". Best practice & research. Clinical gastroenterology. 27 (6): 881-92. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Öberg K, Knigge U, Kwekkeboom D, Perren A (oktober 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (juni 2013). "Pancreatic cystic neoplasms: management and unanswered questions". Gastroenterology. 144 (6): 1303-15. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
PanNET-betegnelsen er i overensstemmelse med WHO-retningslinjerne for klassificering af tumorer i fordøjelsessystemet [3] udgivet i 2010. Historisk er PanNET'er også blevet henvist til med flere andre begreber, og kaldes stadig ofte "pankreatiske endokrine tumorer". Se: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (august 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems" (PDF). Pancreas. 39 (6): 707-12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. Arkiveret fra originalen (PDF) 24. september 2015. Hentet 5. januar 2017.
Burns WR, Edil BH (marts 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". Current treatment options in oncology. 13 (1): 24-34. doi:10.1007/s11864-011-0172-2. PMID 22198808.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Sperti C, Moletta L, Patanè G (15. oktober 2014). "Metastatic tumors to the pancreas: The role of surgery". World Journal of Gastrointestinal Oncology. 6 (10): 381-92. doi:10.4251/wjgo.v6.i10.381. PMID 25320654.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (juli 2012). "Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)". Annals of Oncology. 23 (7): 1880-8. doi:10.1093/annonc/mdr541. PMID 22104574.
Peters, ML; Tseng, JF; Miksad, RA (31. marts 2016). "Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment". Clinical therapeutics. 38: 1622-35. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Greenhalf W, Grocock C, Harcus M, Neoptolemos J (2009). "Screening of high-risk families for pancreatic cancer". Pancreatology. 9 (3): 215-22. doi:10.1159/000210262. PMID 19349734.
Larsson SC, Wolk A (januar 2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". Br J Cancer. Online first (3): 603-7. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Fitzgerald JE, White MJ, Lobo DN (april 2009). "Courvoisier's gallbladder: law or sign?" (PDF). World Journal of Surgery. 33 (4): 886-91. doi:10.1007/s00268-008-9908-y. PMID 19190960. Arkiveret fra originalen den 5. januar 2015. Hentet 6. januar 2017.{{cite journal}}: CS1-vedligeholdelse: BOT: original-url status ukendt (link)
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (oktober 2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii33-40. doi:10.1093/annonc/mds224. PMID 22997452.
Cascinu S, Falconi M, Valentini V, Jelic S (maj 2010). "Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 21 Suppl 5: v55-8. doi:10.1093/annonc/mdq165. PMID 20555103.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Curr Genomics. 12 (1): 15-24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Lewis MA, Yao JC (februar 2014). "Molecular pathology and genetics of gastrointestinal neuroendocrine tumours". Current Opinion in Endocrinology & Diabetes and Obesity. 21 (1): 22-7. doi:10.1097/MED.0000000000000033. PMID 24310147.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (september 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)" (PDF). The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990-3011. doi:10.1210/jc.2012-1230. PMID 22723327. Arkiveret fra originalen (PDF) 17. februar 2015. Hentet 6. januar 2017.
He XY, Yuan YZ (august 2014). "Advances in pancreatic cancer research: moving towards early detection". World J. Gastroenterol. 20 (32): 11241-8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (august 2014). "Strategies for early detection of resectable pancreatic cancer". World J. Gastroenterol. 20 (32): 11230-40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Stoita A, Penman ID, Williams DB (maj 2011). "Review of screening for pancreatic cancer in high risk individuals". World J. Gastroenterol. 17 (19): 2365-71. doi:10.3748/wjg.v17.i19.2365. PMC 3103788. PMID 21633635.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (2014). "Cochrane Database of Systematic Reviews". The Cochrane database of systematic reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (2011). "Arterial resection during pancreatectomy for pancreatic cancer: A systematic review and meta-analysis". Annals of Surgery. 254 (6): 882-93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ (2014). "Improving outcomes in pancreatic cancer: key points in perioperative management". World J. Gastroenterol. 20 (39): 14237-45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.
Lopez NE, Prendergast C, Lowy AM (2014). "Borderline resectable pancreatic cancer: definitions and management". World J. Gastroenterol. 20 (31): 10740-51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (2014). "Neoadjuvant strategies for pancreatic cancer". World J. Gastroenterol. 20 (28): 9374-83. doi:10.3748/wjg.v20.i28.9374 (inaktiv 2016-06-20). PMC 4110569. PMID 25071332.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010). "Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages". PLoS Med. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.
Christians KK, Evans DB (2014). "Additional Support for Neoadjuvant Therapy in the Management of Pancreatic Cancer". Ann. Surg. Oncol. 22 (6): 1755-8. doi:10.1245/s10434-014-4307-0. PMID 25519932.
Tsvetkova EV, Asmis TR (2014). "Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?". Curr Oncol. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY (2015). "Pancreatic cancer stem cells: New insight into a stubborn disease". Cancer Lett. 357 (2): 429-37. doi:10.1016/j.canlet.2014.12.004. PMID 25499079.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R (2014). "Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790-801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (2013). "Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer". Cochrane Database Syst Rev. 11 (11): CD009323. doi:10.1002/14651858.CD009323.pub2. PMID 24272022.
Heinemann V, Haas M, Boeck S (oktober 2013). "Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer". Annals of Oncology. 24 (10): 2484-92. doi:10.1093/annonc/mdt239. PMID 23852311.
Borazanci E, Von Hoff DD; Von Hoff, DD (september 2014). "Nab-paclitaxel and gemcitabine for the treatment of people with metastatic pancreatic cancer". Expert Rev Gastroenterol Hepatol. 8 (7): 739-47. doi:10.1586/17474124.2014.925799. PMID 24882381.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP, O'Toole D (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: Well-differentiated pancreatic non-functioning tumors". Neuroendocrinology. 95 (2): 120-34. doi:10.1159/000335587. PMID 22261872.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: Functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98-119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B, Salazar R (2012). "ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary". Neuroendocrinology. 95 (2): 157-76. doi:10.1159/000335597. PMID 22262022.
Rossi RE, Massironi S, Conte D, Peracchi M (2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01 (inaktiv 2016-06-20). PMC 4200651. PMID 25332984.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Tejani MA, Saif MW (2014). "Pancreatic neuroendocrine tumors: Does chemotherapy work?". JOP: Journal of the pancreas. 15 (2): 132-4. doi:10.6092/1590-8577/2301 (inaktiv 2016-06-20). PMID 24618436.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (2012). "Radionuclide therapy in neuroendocrine tumours: A systematic review". Clinical Oncology. 24 (4): 294-308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (2014). "Advances in Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors (PNETS)". Endocrine Practice. 20 (11): 1-23. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (2010). "Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors". Seminars in Nuclear Medicine. 40 (2): 78-88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (2014). "Peptide receptor radionuclide therapy for advanced neuroendocrine tumors". Thoracic Surgery Clinics. 24 (3): 333-49. doi:10.1016/j.thorsurg.2014.04.005. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (2014). "Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors". Cancer Chemotherapy and Pharmacology. 75 (6): 1099-114. doi:10.1007/s00280-014-2642-2. PMID 25480314.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, Mukhtar T, Pasieka J, Rayson D, Rowsell C, Sideris L, Wong R, Law C (2014). "Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group". Annals of Surgical Oncology. 22 (8): 2685-99. doi:10.1245/s10434-014-4145-0. PMID 25366583.
Buanes TA (14. august 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405-18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (2011). Arcidiacono PG (red.). "Celiac plexus block for pancreatic cancer pain in adults". Cochrane Database Syst Rev (3): CD007519. doi:10.1002/14651858.CD007519.pub2. PMID 21412903.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, et al. (december 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095-128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (1983). "History of the pancreas" (PDF). American Journal of Surgery. 146 (5): 539-50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (juni 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377-84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (juli 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10-5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, Lillemoe KD, Warshaw AL (september 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Wolpin BM, Stampfer MJ (juli 2009). "Defining determinants of pancreatic cancer risk: are we making progress?". J. Natl. Cancer Inst. 101 (14): 972-3. doi:10.1093/jnci/djp182. PMID 19561317.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, et al. (november 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399-405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". Lancet Oncol. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (november 2014). "Pancreatic cancer genomics: where can the science take us?". Clin. Genet. 88 (3): 213-9. doi:10.1111/cge.12536. PMID 25388820.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (december 2014). "The early diagnosis of pancreatic cancer and diabetes: what's the relationship?". Journal of Gastrointestinal Oncology. 5 (6): 481-8. doi:10.3978/j.issn.2078-6891.2014.055 (inaktiv 2016-06-20). PMC 4226830. PMID 25436129.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Bruenderman EH, Martin RC (13. oktober 2014). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of surgical research. 194 (1): 212-219. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Subar D, Gobardhan PD, Gayet B (2014). "Laparoscopic pancreatic surgery". Best Practice & Research Clinical Gastroenterology. 28 (1): 123-32. doi:10.1016/j.bpg.2013.11.011.
Weiss MJ, Wolfgang CL (2013). "Irreversible electroporation: a novel pancreatic cancer therapy". Current Problems in Cancer. 37 (5): 262-5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180.
Moir J, White SA, French JJ, Littler P, Manas DM (december 2014). "Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 40 (12): 1598-1604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Al Haddad AH, Adrian TE (november 2014). "Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma". Expert Opin Investig Drugs. 23 (11): 1499-515. doi:10.1517/13543784.2014.933206. PMID 25078674.
Adiseshaiah, Pavan P.; Crist, Rachael M.; Hook, Sara S.; McNeil, Scott E. (2016). "Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer". Nature Reviews Clinical Oncology. 13: 750-765. doi:10.1038/nrclinonc.2016.119. ISSN 1759-4774.
Kleger A, Perkhofer L, Seufferlein T (juli 2014). "Smarter drugs emerging in pancreatic cancer therapy". Ann. Oncol. 25 (7): 1260-70. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (august 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825-44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Schober M, Jesenofsky R, Faissner R, Weidenauer C, Hagmann W, Michl P, Heuchel RL, Haas SL, Löhr JM (2014). "Desmoplasia and chemoresistance in pancreatic cancer". Cancers (Basel). 6 (4): 2137-54. doi:10.3390/cancers6042137. PMC 4276960. PMID 25337831.
Rossi ML, Rehman AA, Gondi CS (2014). "Therapeutic options for the management of pancreatic cancer". World J. Gastroenterol. 20 (32): 11142-59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Neesse A, Krug S, Gress TM, Tuveson DA, Michl P (2013). "Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma". Onco Targets Ther. 7: 33-43. doi:10.2147/OTT.S38111. PMC 3872146. PMID 24379681.
Heinemann V, Reni M, Ychou M, Richel DJ, Macarulla T, Ducreux M (februar 2014). "Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies". Cancer Treat. Rev. 40 (1): 118-28. doi:10.1016/j.ctrv.2013.04.004. PMID 23849556.
Fong Y, Ady J, Heffner J, Klein E (2014). "Oncolytic viral therapy for pancreatic cancer: current research and future directions". Oncolytic Virotherapy: 35. doi:10.2147/OV.S53858.
Pavelic J (oktober 2014). "Editorial: combined cancer therapy". Curr. Pharm. Des. 20 (42): 6511-2. doi:10.2174/1381612820666140826154834. PMID 25341927.

enotes.us

Ryan DP, Hong TS, Bardeesy N (september 2014). "Pancreatic adenocarcinoma" (PDF). N. Engl. J. Med. 371 (11): 1039-49. doi:10.1056/NEJMra1404198. PMID 25207767. Arkiveret fra originalen (PDF) 26. december 2014. Hentet 5. januar 2017.

europac-org.eu

"About EUROPAC". European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC). University of Liverpool. Hentet 17. juli 2014.

google.ca

books.google.ca

Handbook of Pancreatic Cancer. New York: Springer. 2009. s. 288. ISBN 978-0-387-77497-8. Hentet 12. juni 2016.

harvard.edu

ui.adsabs.harvard.edu

Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, et al. (november 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399-405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.

iarc.fr

www-dep.iarc.fr

[1] og [2]

jhu.edu

pathology.jhu.edu

"Types of Pancreas Tumors". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Arkiveret fra originalen 8. oktober 2014. Hentet 18. november 2014.
"Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Arkiveret fra originalen 5. januar 2015. Hentet 5. januar 2015.

joplink.net

Bussom S, Saif MW (5. marts 2010). "Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22–24, 2010". JOP : Journal of the pancreas. 11 (2): 128-30. PMID 20208319.

karger.com

content.karger.com

Greenhalf W, Grocock C, Harcus M, Neoptolemos J (2009). "Screening of high-risk families for pancreatic cancer". Pancreatology. 9 (3): 215-22. doi:10.1159/000210262. PMID 19349734.

medicin.dk

pro.medicin.dk

Eksokrin pancreasinsufficiens

medscape.com

Nick Mulcahy (17. december 2014). "FDA Approves Lanreotide for Neuroendocrine Tumors". Medscape Medical News. WebMD LLC. Hentet 25. december 2014.

nature.com

Larsson SC, Wolk A (januar 2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". Br J Cancer. Online first (3): 603-7. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.

nccn.org

"Neuroendocrine tumors, NCCN Guidelines Version 1.2015" (PDF). NCCN Guidelines. National Comprehensive Cancer Network, Inc. 11. november 2014. Hentet 25. december 2014.
"Pancreatic adenocarcinoma. NCCN Guidelines Version 1.2015" (PDF). NCCN Guidelines. National Comprehensive Cancer Network, Inc. 4. december 2014. Hentet 26. december 2014.

nhs.uk

"Causes of pancreatic cancer". NHS Choices. National Health Service, England. 7. oktober 2014. Hentet 5. december 2014.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ryan DP, Hong TS, Bardeesy N (september 2014). "Pancreatic adenocarcinoma" (PDF). N. Engl. J. Med. 371 (11): 1039-49. doi:10.1056/NEJMra1404198. PMID 25207767. Arkiveret fra originalen (PDF) 26. december 2014. Hentet 5. januar 2017.
Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma" (PDF). BMJ (Clinical research ed.). 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847. Arkiveret fra originalen (PDF) 9. januar 2015. Hentet 5. januar 2017.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (september 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318-48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (august 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607-20. doi:10.1016/S0140-6736(10)62307-0. PMID 21620466. Arkiveret fra originalen (PDF) 12. januar 2015. Hentet 5. januar 2017.
Bussom S, Saif MW (5. marts 2010). "Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22–24, 2010". JOP : Journal of the pancreas. 11 (2): 128-30. PMID 20208319.
Shahrokni A, Saif MW (10. juli 2013). "Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life". JOP : Journal of the pancreas. 14 (4): 391-4. doi:10.6092/1590-8577/1663. PMID 23846935.
Bardou M, Le Ray I (december 2013). "Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies". Best practice & research. Clinical gastroenterology. 27 (6): 881-92. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Öberg K, Knigge U, Kwekkeboom D, Perren A (oktober 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (juni 2013). "Pancreatic cystic neoplasms: management and unanswered questions". Gastroenterology. 144 (6): 1303-15. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
PanNET-betegnelsen er i overensstemmelse med WHO-retningslinjerne for klassificering af tumorer i fordøjelsessystemet [3] udgivet i 2010. Historisk er PanNET'er også blevet henvist til med flere andre begreber, og kaldes stadig ofte "pankreatiske endokrine tumorer". Se: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (august 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems" (PDF). Pancreas. 39 (6): 707-12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. Arkiveret fra originalen (PDF) 24. september 2015. Hentet 5. januar 2017.
Burns WR, Edil BH (marts 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". Current treatment options in oncology. 13 (1): 24-34. doi:10.1007/s11864-011-0172-2. PMID 22198808.
De La Cruz MS, Young AP, Ruffin MT (april 2014). "Diagnosis and management of pancreatic cancer". Am Fam Physician. 89 (8): 626-32. PMID 24784121.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Sperti C, Moletta L, Patanè G (15. oktober 2014). "Metastatic tumors to the pancreas: The role of surgery". World Journal of Gastrointestinal Oncology. 6 (10): 381-92. doi:10.4251/wjgo.v6.i10.381. PMID 25320654.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (juli 2012). "Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)". Annals of Oncology. 23 (7): 1880-8. doi:10.1093/annonc/mdr541. PMID 22104574.
Peters, ML; Tseng, JF; Miksad, RA (31. marts 2016). "Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment". Clinical therapeutics. 38: 1622-35. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Greenhalf W, Grocock C, Harcus M, Neoptolemos J (2009). "Screening of high-risk families for pancreatic cancer". Pancreatology. 9 (3): 215-22. doi:10.1159/000210262. PMID 19349734.
Larsson SC, Wolk A (januar 2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". Br J Cancer. Online first (3): 603-7. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Pericleous M, Rossi RE, Mandair D, Whyand T, Caplin ME (januar 2014). "Nutrition and pancreatic cancer". Anticancer research. 34 (1): 9-21. PMID 24403441.
Fitzgerald JE, White MJ, Lobo DN (april 2009). "Courvoisier's gallbladder: law or sign?" (PDF). World Journal of Surgery. 33 (4): 886-91. doi:10.1007/s00268-008-9908-y. PMID 19190960. Arkiveret fra originalen den 5. januar 2015. Hentet 6. januar 2017.{{cite journal}}: CS1-vedligeholdelse: BOT: original-url status ukendt (link)
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (oktober 2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii33-40. doi:10.1093/annonc/mds224. PMID 22997452.
Cascinu S, Falconi M, Valentini V, Jelic S (maj 2010). "Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 21 Suppl 5: v55-8. doi:10.1093/annonc/mdq165. PMID 20555103.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Curr Genomics. 12 (1): 15-24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Lewis MA, Yao JC (februar 2014). "Molecular pathology and genetics of gastrointestinal neuroendocrine tumours". Current Opinion in Endocrinology & Diabetes and Obesity. 21 (1): 22-7. doi:10.1097/MED.0000000000000033. PMID 24310147.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (september 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)" (PDF). The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990-3011. doi:10.1210/jc.2012-1230. PMID 22723327. Arkiveret fra originalen (PDF) 17. februar 2015. Hentet 6. januar 2017.
He XY, Yuan YZ (august 2014). "Advances in pancreatic cancer research: moving towards early detection". World J. Gastroenterol. 20 (32): 11241-8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (august 2014). "Strategies for early detection of resectable pancreatic cancer". World J. Gastroenterol. 20 (32): 11230-40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Stoita A, Penman ID, Williams DB (maj 2011). "Review of screening for pancreatic cancer in high risk individuals". World J. Gastroenterol. 17 (19): 2365-71. doi:10.3748/wjg.v17.i19.2365. PMC 3103788. PMID 21633635.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (2014). "Cochrane Database of Systematic Reviews". The Cochrane database of systematic reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (2011). "Arterial resection during pancreatectomy for pancreatic cancer: A systematic review and meta-analysis". Annals of Surgery. 254 (6): 882-93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ (2014). "Improving outcomes in pancreatic cancer: key points in perioperative management". World J. Gastroenterol. 20 (39): 14237-45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.
Lopez NE, Prendergast C, Lowy AM (2014). "Borderline resectable pancreatic cancer: definitions and management". World J. Gastroenterol. 20 (31): 10740-51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (2014). "Neoadjuvant strategies for pancreatic cancer". World J. Gastroenterol. 20 (28): 9374-83. doi:10.3748/wjg.v20.i28.9374 (inaktiv 2016-06-20). PMC 4110569. PMID 25071332.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010). "Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages". PLoS Med. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.
Christians KK, Evans DB (2014). "Additional Support for Neoadjuvant Therapy in the Management of Pancreatic Cancer". Ann. Surg. Oncol. 22 (6): 1755-8. doi:10.1245/s10434-014-4307-0. PMID 25519932.
Tsvetkova EV, Asmis TR (2014). "Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?". Curr Oncol. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY (2015). "Pancreatic cancer stem cells: New insight into a stubborn disease". Cancer Lett. 357 (2): 429-37. doi:10.1016/j.canlet.2014.12.004. PMID 25499079.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R (2014). "Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790-801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (2013). "Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer". Cochrane Database Syst Rev. 11 (11): CD009323. doi:10.1002/14651858.CD009323.pub2. PMID 24272022.
Heinemann V, Haas M, Boeck S (oktober 2013). "Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer". Annals of Oncology. 24 (10): 2484-92. doi:10.1093/annonc/mdt239. PMID 23852311.
Borazanci E, Von Hoff DD; Von Hoff, DD (september 2014). "Nab-paclitaxel and gemcitabine for the treatment of people with metastatic pancreatic cancer". Expert Rev Gastroenterol Hepatol. 8 (7): 739-47. doi:10.1586/17474124.2014.925799. PMID 24882381.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP, O'Toole D (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: Well-differentiated pancreatic non-functioning tumors". Neuroendocrinology. 95 (2): 120-34. doi:10.1159/000335587. PMID 22261872.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: Functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98-119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B, Salazar R (2012). "ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary". Neuroendocrinology. 95 (2): 157-76. doi:10.1159/000335597. PMID 22262022.
Rossi RE, Massironi S, Conte D, Peracchi M (2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01 (inaktiv 2016-06-20). PMC 4200651. PMID 25332984.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Tejani MA, Saif MW (2014). "Pancreatic neuroendocrine tumors: Does chemotherapy work?". JOP: Journal of the pancreas. 15 (2): 132-4. doi:10.6092/1590-8577/2301 (inaktiv 2016-06-20). PMID 24618436.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (2012). "Radionuclide therapy in neuroendocrine tumours: A systematic review". Clinical Oncology. 24 (4): 294-308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (2014). "Advances in Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors (PNETS)". Endocrine Practice. 20 (11): 1-23. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (2010). "Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors". Seminars in Nuclear Medicine. 40 (2): 78-88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (2014). "Peptide receptor radionuclide therapy for advanced neuroendocrine tumors". Thoracic Surgery Clinics. 24 (3): 333-49. doi:10.1016/j.thorsurg.2014.04.005. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (2014). "Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors". Cancer Chemotherapy and Pharmacology. 75 (6): 1099-114. doi:10.1007/s00280-014-2642-2. PMID 25480314.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, Mukhtar T, Pasieka J, Rayson D, Rowsell C, Sideris L, Wong R, Law C (2014). "Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group". Annals of Surgical Oncology. 22 (8): 2685-99. doi:10.1245/s10434-014-4145-0. PMID 25366583.
Buanes TA (14. august 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405-18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (2011). Arcidiacono PG (red.). "Celiac plexus block for pancreatic cancer pain in adults". Cochrane Database Syst Rev (3): CD007519. doi:10.1002/14651858.CD007519.pub2. PMID 21412903.
Thota R, Pauff JM, Berlin JD (januar 2014). "Treatment of metastatic pancreatic adenocarcinoma: a review". Oncology (Williston Park, N.Y.). 28 (1): 70-4. PMID 24683721.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, et al. (december 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095-128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (1983). "History of the pancreas" (PDF). American Journal of Surgery. 146 (5): 539-50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (juni 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377-84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (juli 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10-5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, Lillemoe KD, Warshaw AL (september 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Wolpin BM, Stampfer MJ (juli 2009). "Defining determinants of pancreatic cancer risk: are we making progress?". J. Natl. Cancer Inst. 101 (14): 972-3. doi:10.1093/jnci/djp182. PMID 19561317.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, et al. (november 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399-405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". Lancet Oncol. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (november 2014). "Pancreatic cancer genomics: where can the science take us?". Clin. Genet. 88 (3): 213-9. doi:10.1111/cge.12536. PMID 25388820.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (december 2014). "The early diagnosis of pancreatic cancer and diabetes: what's the relationship?". Journal of Gastrointestinal Oncology. 5 (6): 481-8. doi:10.3978/j.issn.2078-6891.2014.055 (inaktiv 2016-06-20). PMC 4226830. PMID 25436129.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Bruenderman EH, Martin RC (13. oktober 2014). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of surgical research. 194 (1): 212-219. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Weiss MJ, Wolfgang CL (2013). "Irreversible electroporation: a novel pancreatic cancer therapy". Current Problems in Cancer. 37 (5): 262-5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180.
Moir J, White SA, French JJ, Littler P, Manas DM (december 2014). "Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 40 (12): 1598-1604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Al Haddad AH, Adrian TE (november 2014). "Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma". Expert Opin Investig Drugs. 23 (11): 1499-515. doi:10.1517/13543784.2014.933206. PMID 25078674.
Kleger A, Perkhofer L, Seufferlein T (juli 2014). "Smarter drugs emerging in pancreatic cancer therapy". Ann. Oncol. 25 (7): 1260-70. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (august 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825-44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Schober M, Jesenofsky R, Faissner R, Weidenauer C, Hagmann W, Michl P, Heuchel RL, Haas SL, Löhr JM (2014). "Desmoplasia and chemoresistance in pancreatic cancer". Cancers (Basel). 6 (4): 2137-54. doi:10.3390/cancers6042137. PMC 4276960. PMID 25337831.
Rossi ML, Rehman AA, Gondi CS (2014). "Therapeutic options for the management of pancreatic cancer". World J. Gastroenterol. 20 (32): 11142-59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Neesse A, Krug S, Gress TM, Tuveson DA, Michl P (2013). "Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma". Onco Targets Ther. 7: 33-43. doi:10.2147/OTT.S38111. PMC 3872146. PMID 24379681.
Heinemann V, Reni M, Ychou M, Richel DJ, Macarulla T, Ducreux M (februar 2014). "Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies". Cancer Treat. Rev. 40 (1): 118-28. doi:10.1016/j.ctrv.2013.04.004. PMID 23849556.
Pavelic J (oktober 2014). "Editorial: combined cancer therapy". Curr. Pharm. Des. 20 (42): 6511-2. doi:10.2174/1381612820666140826154834. PMID 25341927.

ncbi.nlm.nih.gov

Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (september 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318-48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
PanNET-betegnelsen er i overensstemmelse med WHO-retningslinjerne for klassificering af tumorer i fordøjelsessystemet [3] udgivet i 2010. Historisk er PanNET'er også blevet henvist til med flere andre begreber, og kaldes stadig ofte "pankreatiske endokrine tumorer". Se: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (august 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems" (PDF). Pancreas. 39 (6): 707-12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. Arkiveret fra originalen (PDF) 24. september 2015. Hentet 5. januar 2017.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Larsson SC, Wolk A (januar 2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". Br J Cancer. Online first (3): 603-7. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Curr Genomics. 12 (1): 15-24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
He XY, Yuan YZ (august 2014). "Advances in pancreatic cancer research: moving towards early detection". World J. Gastroenterol. 20 (32): 11241-8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (august 2014). "Strategies for early detection of resectable pancreatic cancer". World J. Gastroenterol. 20 (32): 11230-40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Stoita A, Penman ID, Williams DB (maj 2011). "Review of screening for pancreatic cancer in high risk individuals". World J. Gastroenterol. 17 (19): 2365-71. doi:10.3748/wjg.v17.i19.2365. PMC 3103788. PMID 21633635.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ (2014). "Improving outcomes in pancreatic cancer: key points in perioperative management". World J. Gastroenterol. 20 (39): 14237-45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.
Lopez NE, Prendergast C, Lowy AM (2014). "Borderline resectable pancreatic cancer: definitions and management". World J. Gastroenterol. 20 (31): 10740-51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (2014). "Neoadjuvant strategies for pancreatic cancer". World J. Gastroenterol. 20 (28): 9374-83. doi:10.3748/wjg.v20.i28.9374 (inaktiv 2016-06-20). PMC 4110569. PMID 25071332.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010). "Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages". PLoS Med. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.
Tsvetkova EV, Asmis TR (2014). "Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?". Curr Oncol. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R (2014). "Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790-801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: Functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98-119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Rossi RE, Massironi S, Conte D, Peracchi M (2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01 (inaktiv 2016-06-20). PMC 4200651. PMID 25332984.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Buanes TA (14. august 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405-18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Are C, Dhir M, Ravipati L (juni 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377-84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (juli 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10-5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, Lillemoe KD, Warshaw AL (september 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, et al. (november 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399-405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Pannala R, Basu A, Petersen GM, Chari ST (januar 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". Lancet Oncol. 10 (1): 88-95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (december 2014). "The early diagnosis of pancreatic cancer and diabetes: what's the relationship?". Journal of Gastrointestinal Oncology. 5 (6): 481-8. doi:10.3978/j.issn.2078-6891.2014.055 (inaktiv 2016-06-20). PMC 4226830. PMID 25436129.{{cite journal}}: CS1-vedligeholdelse: DOI inaktiv siden juni 2016 (link)
Bruenderman EH, Martin RC (13. oktober 2014). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of surgical research. 194 (1): 212-219. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Tang SC, Chen YC (august 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825-44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Schober M, Jesenofsky R, Faissner R, Weidenauer C, Hagmann W, Michl P, Heuchel RL, Haas SL, Löhr JM (2014). "Desmoplasia and chemoresistance in pancreatic cancer". Cancers (Basel). 6 (4): 2137-54. doi:10.3390/cancers6042137. PMC 4276960. PMID 25337831.
Rossi ML, Rehman AA, Gondi CS (2014). "Therapeutic options for the management of pancreatic cancer". World J. Gastroenterol. 20 (32): 11142-59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Neesse A, Krug S, Gress TM, Tuveson DA, Michl P (2013). "Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma". Onco Targets Ther. 7: 33-43. doi:10.2147/OTT.S38111. PMC 3872146. PMID 24379681.

onkologisktidsskrift.dk

Uafgjort mellem to behandlinger af bugspytkirtelkræft

oxfordjournals.org

annonc.oxfordjournals.org

Öberg K, Knigge U, Kwekkeboom D, Perren A (oktober 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (oktober 2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7: vii33-40. doi:10.1093/annonc/mds224. PMID 22997452.
Cascinu S, Falconi M, Valentini V, Jelic S (maj 2010). "Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 21 Suppl 5: v55-8. doi:10.1093/annonc/mdq165. PMID 20555103.
Kleger A, Perkhofer L, Seufferlein T (juli 2014). "Smarter drugs emerging in pancreatic cancer therapy". Ann. Oncol. 25 (7): 1260-70. doi:10.1093/annonc/mdu013. PMID 24631947.

jnci.oxfordjournals.org

Wolpin BM, Stampfer MJ (juli 2009). "Defining determinants of pancreatic cancer risk: are we making progress?". J. Natl. Cancer Inst. 101 (14): 972-3. doi:10.1093/jnci/djp182. PMID 19561317.

pancreaticcancer.net.au

"Australian Pancreatic Genome Initiative". Garvan Institute. Hentet 17. juli 2014.

sciencedirect.com

Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (1983). "History of the pancreas" (PDF). American Journal of Surgery. 146 (5): 539-50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.

seen.es

PanNET-betegnelsen er i overensstemmelse med WHO-retningslinjerne for klassificering af tumorer i fordøjelsessystemet [3] udgivet i 2010. Historisk er PanNET'er også blevet henvist til med flere andre begreber, og kaldes stadig ofte "pankreatiske endokrine tumorer". Se: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (august 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems" (PDF). Pancreas. 39 (6): 707-12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. Arkiveret fra originalen (PDF) 24. september 2015. Hentet 5. januar 2017.

sundhed.dk

https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/mave-tarm/tilstande-og-sygdomme/bugspytkirtel/pankreaskraeft/

web.archive.org

Ryan DP, Hong TS, Bardeesy N (september 2014). "Pancreatic adenocarcinoma" (PDF). N. Engl. J. Med. 371 (11): 1039-49. doi:10.1056/NEJMra1404198. PMID 25207767. Arkiveret fra originalen (PDF) 26. december 2014. Hentet 5. januar 2017.
Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma" (PDF). BMJ (Clinical research ed.). 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847. Arkiveret fra originalen (PDF) 9. januar 2015. Hentet 5. januar 2017.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (august 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607-20. doi:10.1016/S0140-6736(10)62307-0. PMID 21620466. Arkiveret fra originalen (PDF) 12. januar 2015. Hentet 5. januar 2017.
"Can pancreatic cancer be prevented?". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 13. november 2014. Hentet 13. november 2014.
"Cancer Facts & Figures 2010" (PDF). American Cancer Society. 2010. Arkiveret fra originalen (PDF) 14. januar 2015. Hentet 5. december 2014. See p. 4 for incidence estimates, and p. 19 for survival percentages.
"Types of Pancreas Tumors". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Arkiveret fra originalen 8. oktober 2014. Hentet 18. november 2014.
PanNET-betegnelsen er i overensstemmelse med WHO-retningslinjerne for klassificering af tumorer i fordøjelsessystemet [3] udgivet i 2010. Historisk er PanNET'er også blevet henvist til med flere andre begreber, og kaldes stadig ofte "pankreatiske endokrine tumorer". Se: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (august 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems" (PDF). Pancreas. 39 (6): 707-12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. Arkiveret fra originalen (PDF) 24. september 2015. Hentet 5. januar 2017.
"Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Arkiveret fra originalen 5. januar 2015. Hentet 5. januar 2015.
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Arkiveret fra originalen (PDF) 18. december 2014. Hentet 5. januar 2015., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
Fitzgerald JE, White MJ, Lobo DN (april 2009). "Courvoisier's gallbladder: law or sign?" (PDF). World Journal of Surgery. 33 (4): 886-91. doi:10.1007/s00268-008-9908-y. PMID 19190960. Arkiveret fra originalen den 5. januar 2015. Hentet 6. januar 2017.{{cite journal}}: CS1-vedligeholdelse: BOT: original-url status ukendt (link)
"Staging of pancreatic cancer". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 10. august 2020. Hentet 29. september 2014.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (september 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)" (PDF). The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990-3011. doi:10.1210/jc.2012-1230. PMID 22723327. Arkiveret fra originalen (PDF) 17. februar 2015. Hentet 6. januar 2017.
"Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section". American Cancer Society. 20. august 2012. Arkiveret fra originalen 4. november 2014. Hentet 4. november 2014.
Everolimus Approved for Pancreatic Neuroendocrine Tumors Arkiveret 16. juli 2016 hos Wayback Machine The ASCO Post. May 15, 2011, Volume 2, Issue 8
National Cancer Institute. Cancer Drug Information. FDA Approval for Sunitinib Malate Arkiveret 5. januar 2015 hos Wayback Machine. Pancreatic Neuroendocrine Tumors
Text is available electronically (but may require free registration) See: Benson AB, Myerson RJ, Sasson AR. Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach 13th edition 2010. ISBN 978-0-615-41824-7. Arkiveret fra originalen 15. maj 2011. Hentet 7. januar 2017.
"Palliative or Supportive Care". American Cancer Society. 2014. Arkiveret fra originalen 21. august 2014. Hentet 20. august 2014.
"If treatment for pancreatic cancer stops working". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 2014-10-22. Hentet 20. august 2014.
Zyromski, Nicholas J.; Nakeeb, Attila; Lillemoe, Keith D. (2010). Silberman, Howard; Silberman, Allan W. (red.). Principles and practice of surgical oncology : multidisciplinary approach to difficult problems (online udgave). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. Chapter 35. ISBN 978-0-7817-6546-6. Arkiveret fra originalen den 6. februar 2015. Hentet 3. november 2014.{{cite book}}: CS1-vedligeholdelse: BOT: original-url status ukendt (link)
"What's new in pancreatic cancer research and treatment?". American Cancer Society. 11. juni 2014. Arkiveret fra originalen 29. november 2016. Hentet 17. juli 2014.
"Pancreatic cancer research". Cancer Research UK. Arkiveret fra originalen 18. februar 2014. Hentet 17. juli 2014.

wessexcolorectalclinic.com

Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma" (PDF). BMJ (Clinical research ed.). 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847. Arkiveret fra originalen (PDF) 9. januar 2015. Hentet 5. januar 2017.

wjgnet.com

Tang SC, Chen YC (august 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825-44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.

worldcat.org

Adiseshaiah, Pavan P.; Crist, Rachael M.; Hook, Sara S.; McNeil, Scott E. (2016). "Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer". Nature Reviews Clinical Oncology. 13: 750-765. doi:10.1038/nrclinonc.2016.119. ISSN 1759-4774.

zju.edu.cn

m-learning.zju.edu.cn

Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (august 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607-20. doi:10.1016/S0140-6736(10)62307-0. PMID 21620466. Arkiveret fra originalen (PDF) 12. januar 2015. Hentet 5. januar 2017.